Cartesian Therapeutics
RNAC
#7447
Rank
S$0.41 B
Marketcap
$15.85
Share price
2.28%
Change (1 day)
-47.14%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are S$38.91 Million. , an increase over its 2023 earnings that were of -S$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.11 Billion-67.3%
2023 -S$0.31 Billion-724%
2022 S$49.5 M-649.67%
2021 -S$9.01 Million-89.78%
2020 -S$88.17 Million25.06%
2019 -S$70.5 Million-15.68%
2018 -S$83.61 Million-0.43%
2017 -S$83.97 Million83.41%
2016 -S$45.79 Million44.3%
2015 -S$31.73 Million